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Specific Ablation of Stat3 Distorts the Pattern
of Stat3-Responsive Gene Expression
and Impairs Recovery from Endotoxic Shock
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Hepatocytes devoid of Stat3 exhibit impaired induction
of a subset of acute phase proteins, including serum
amyloid P (SAP), serum amyloid A (SAA) isoforms, hap-
toglobin, fibrinogen , and fibrinogen  (Alonzi et al.,
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2001). Disruption of the Stat3 gene in macrophages re-The Johns Hopkins University School of Medicine
sults in massive overproduction of TNF and IL-6 uponBaltimore, Maryland 21205
treatment with bacterial lipopolysaccharide (LPS)
(Takeda et al., 1999). In thymic epithelial cells, Stat3 is
essential for survival of thymocytes (Sano et al., 2001),Summary
while in T lymphocytes, Stat3 deficiency is associated
with impairment of the antiapoptotic effect of IL-6Alternative splicing of the gene for Stat3, a transcrip-
(Takeda et al., 1998). Ablation of Stat3 in keratinocytestion factor activated by the IL-6 family of cytokines,
is associated with defects in skin remodeling and hairproduces two isoforms: Stat3 and a dominant-nega-
growth (Sano et al., 1999), and in mammary epithelialtive variant, Stat3. Stat3-deficient mice were gener-
cells Stat3 is apparently essential for the involution ofated by gene targeting. Despite intact expression and
breast tissue that normally occurs after weaning (Chap-phosphorylation of Stat3, overall Stat3 activity was
man et al., 1999).impaired in Stat3/ cells. Global comparison of
Stat3 orthologs are found in diverse vertebrate spe-transcription in Stat3/ and Stat3/ cells revealed
cies. Mammals produce an alternatively spliced isoform,stable differences. Stat3-deficient mice exhibit di-
Stat3, in which the 55 carboxy-terminal amino acidminished recovery from endotoxic shock and hyper-
residues of Stat3, spanning the intrinsic transactivationresponsiveness of a subset of endotoxin-inducible
domain, are replaced by seven distinct residues (Cal-genes in liver. The hepatic response to endotoxin in
denhoven et al., 1996; Schaefer et al., 1995). Stat3wild-type mice is accompanied by a transient increase
and Stat3 exhibit overlapping but distinct biochemicalin the ratio of Stat3 to Stat3. These findings indicate
properties. They are phosphorylated on tyrosine by simi-a critical role for Stat3 in the control of systemic
lar activators, and both can form homodimers and het-inflammation.
erodimers with each other or with the related transcrip-
tion factor Stat1 in transfected cells (Caldenhoven etIntroduction
al., 1996; Schaefer et al., 1997). Stat3 and Stat3 homo-
dimers bind identical DNA sites with similar rates ofThe acute phase response (APR) is an innate, systemic
association and dissociation, but Stat3 dimers areinflammatory reaction with diverse triggers, including
more stable; as a result, Stat3 exhibits greater overalltrauma and infection (Ramadori and Christ, 1999). Sev-
DNA binding activity than Stat3 in vitro (Park et al.,eral cytokines, including IL-1, tumor necrosis factor 
2000).(TNF), and IL-6, are produced at a site of local inflam-
The known contributions of Stat3 to transcriptionalmation and act on hepatocytes to stimulate or suppress
regulation differ markedly from those of Stat3. Asthe synthesis of acute phase proteins (Gabay and Kush-
Stat3 lacks an intrinsic activation domain, it can actner, 1999). IL-6 exerts its effects on APR genes princi-
as a dominant-negative form of Stat3 (Caldenhoven etpally through the latent transcription factor signal trans-
al., 1996). Although Stat3 cannot activate IL-6-respon-
ducer and activator of transcription 3 (Stat3) (Akira et
sive promoters, it can cooperate with transcription
al., 1994; Zhong et al., 1994; Ihle et al., 1998; Schindler
factors such as c-jun to stimulate gene expression
and Darnell, 1995). (Schaefer et al., 1995, 1997). Moreover, Stat3 can ex-
Stat3 is activated upon phosphorylation of tyrosine hibit special functions through association with Stat3,
705 by Janus (Jak) in response to IL-6 and related cyto- as evidenced by the particular ability of Stat3/ hetero-
kines such as leukemia inhibitory factor (LIF) or onco- dimers to suppress Fas promoter activity (Ivanov et al.,
statin M (OSM) (Leonard and O’Shea, 1998; Park et al., 2001).
1996; Zhong et al., 1994). Stat3 functions in several pro- To more definitively assess the biological functions
cesses aside from the APR, including stem cell renewal, of Stat3, as distinct from Stat3, we have generated
cellular differentiation, and malignant transformation mice that are selectively unable to synthesize the Stat3
(Barasch et al., 1999; Besser et al., 1999; Bonni et al., isoform. Selective ablation of Stat3, in contrast to abla-
1997; Hauser et al., 1998; Kunisada et al., 2000; Masca- tion of Stat3, is associated with normal production of
reno et al., 1998; Niwa et al., 1998; Raz et al., 1999; IL-6, IL-1, and TNF by LPS-treated macrophages.
Takemoto et al., 1997; Turkson et al., 1998). Nonetheless, upon challenge with endotoxin, Stat3-
While conventional disruption of the Stat3 gene re- deficient mice exhibit impaired recovery and marked
sults in early embryonic lethality (Takeda et al., 1997), susceptibility to protracted shock, as evidenced by
tissue-specific ablation of Stat3 has yielded more in- widespread renal tubular necrosis. These findings are
structive phenotypes (Alonzi et al., 2001; Chapman et accompanied by chronic overexpression and hyperre-
sponsiveness of a subset of LPS-inducible genes. Taken
together, our observations uncover distinctive roles for3 Correspondence: sdesider@jhmi.edu
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Stat3 in modulating Stat3 activity and in regulating chimeric mice capable of transmitting the Stat3 allele
in the germline. Stat3/ mice were obtained by inter-systemic inflammation.
breeding Stat3/ progeny (Figure 2C).
Results
Specific Ablation of Stat3 mRNA and Stat3
Protein in Homozygous Mutant MiceSpecific Ablation of Stat3 RNA by Mutation
of a Cryptic Splice Acceptor Site We first wished to determine whether formation of the
Stat3 mRNA isoform was abrogated in Stat3/ mice.The Stat3 cDNA isoform, as obtained from hepatocytes
or eosinophils, possesses an internal deletion relative Stat3 and Stat3mRNA isoforms were both expressed
in livers of wild-type and Stat3 heterozygous mice (Fig-to Stat3. This deletion, which spans the first 50 nucleo-
tides of exon 23, gives rise to a frameshift that introduces ure 2D, top, Stat3/ and Stat3/). In contrast, only
the Stat3 mRNA isoform was detected in livers ofseven alternative amino acids followed by a termination
codon. Thus, the resulting Stat3 protein lacks 55 amino Stat3/ mice (Figure 2D, top, Stat3/), as would be
expected if alternative splicing to the Stat3 isoformacid residues found at the carboxyl terminus of Stat3,
including Ser727, whose phosphorylation stimulates were blocked. Moreover, the overall amount of Stat3
transcript was not significantly altered in Stat3/ mice,transactivation (Figure 1A).
To understand the origin of Stat3 transcripts, we first as compared to wild-type and with reference to  actin
transcripts (Figure 2D, bottom). The absence of Stat3scanned exon 23 for a possible intron-exon junction. In
higher eukaryotes, splice acceptor sites are generally tanscripts in homozygous mutant mice was confirmed
using an assay specific for the  RNA isoform (Figuredistinguished by a polypyrimidine tract followed by an
AG dinucleotide (Sharp and Burge, 1997). Analysis of 2D, middle).
We next examined the expression and activation ofexon 23 revealed an embedded splice acceptor site,
consisting of a pyrimidine-rich interval and an AG dinu- Stat3 protein isoforms. Embryonic fibroblasts (MEFs)
were prepared from 12- to 14-day embryos. After over-cleotide corresponding to the 3 boundary of the 50
nucleotide Stat3 deletion (Figure 1B). The putative night culture in 0.5% fetal bovine serum, cells were ana-
lyzed without further treatment or after treatment withsplice acceptor dinucleotide is conserved in mammals
but is absent from all nonmammalian vertebrate species IL-6, OSM, LIF, IFN, or EGF. Stat3 and Stat3 were
detected in lysates of wild-type or Stat3/ cells (Figureexamined (Figure 1C). It seemed likely that Stat3 tran-
scripts arise from use of this splice acceptor site, which 3A, Stat3/ and Stat3/, lower gels); both isoforms
were phosphorylated on tyrosine in response to OSMwould result in removal of the first 50 nucleotides of
exon 23. To test this possibility, we constructed a Stat3 or LIF (Figure 3A, Stat3/ and Stat3/, upper gels).
In contrast, only the Stat3 isoform was detected inminigene (Figure 1D) that supports production of Stat3
and Stat3 RNA fragments in Cos-7 cells (Figure 1E, MEFs from Stat3/ embryos (Figure 3A, Stat3/,
lower gel). Importantly, tyrosine phosphorylation oflane 1). We then mutated the putative Stat3 splice ac-
ceptor site at the polypyrimidine tract (Figure 1D, YI, YII, Stat3 in response to OSM and LIF was unperturbed in
Stat3/ cells (Figure 3A, Stat3/, upper gel). Theseand YIII), the AG dinucleotide (Figure 1D, TG), or both
(Figure 1D, YITG, YIITG, and YIIITG). The mutations were experiments confirmed that knockin of the YIIITG splice
acceptor mutation effectively ablated expression of theselected so that the coding sense of exon 23 was not
altered and codon biases were not significantly per- Stat3 protein isoform but spared expression and acti-
vation of Stat3.turbed. Production of Stat3 RNA was abolished by all
splicing mutations tested (Figure 1E, lanes 3–9) but was
unperturbed by introduction of an upstream MfeI restric- Impairment of Stat3 DNA Binding Activity
tion site (Figure 1E, lane 2). We thereby verified use of in Stat3-Deficient Cells
the cryptic splice acceptor site in exon 23 and acquired Although Stat3 and Stat3 exhibit similar DNA binding
means to achieve specific ablation of the Stat3 isoform. affinities, the stability of Stat3 dimers is significantly
greater (Park et al., 2000). Thus, the contribution of
Stat3 to overall Stat3 DNA binding activity is not readilyGeneration of Stat3-Deficient Mice
To generate a Stat3 allele incapable of producing Stat3 predictable from its abundance relative to Stat3. Hav-
ing determined that ablation of Stat3 did not alter ex-mRNA, the wild-type exon 23 was replaced with a mu-
tated exon 23, bearing the YIIITG mutation described pression or tyrosine phosphorylation of Stat3, it was
of interest to compare overall Stat3 DNA binding activityabove and tagged with a novel MfeI restriction site (Fig-
ure 2A). After transfection of the targeting construct in wild-type, heterozygous, and Stat3-deficient set-
tings.into 129/SvJ embryonic stem (ES) cells, homologous
recombinants were obtained by selection in G418 (Fig- In serum-starved, wild-type MEFs, DNA binding activ-
ity specific for the sis-inducible element (SIE) was in-ure 2B, left). Following introduction of a cre recombinase
expression plasmid, cells that had undergone excision duced by OSM, LIF, and to a lesser extent IL-6 (Figure
3B, lanes 3–5). These DNA-protein complexes wereof the loxP-flanked TK-neo cassette were selected in
the presence of gancyclovir (Figure 2B, right). Analysis shown by an antibody-induced supershift assay to con-
tain Stat3 but not detectable amounts of Stat1 (Figureof genomic DNA sequence confirmed the introduction
of the YIIITG splice acceptor site mutation and the MfeI 3E, left). The yield of inducible, SIE binding complexes
was reduced in serum-starved, Stat3/ MEFs (Figurerestriction site into exon 23 of the mutant allele, which
hereafter will be termed the Stat3 allele. Stat3/ 3B, lanes 9–11) and diminished further in Stat3/ cells
(Figure 3B, lanes 15–17). In contrast, when equivalentembryonic stem cell clones were used to obtain male,
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Figure 1. A Splice Acceptor Embedded in the Stat3 Coding Sequence Specifies the Stat3 Transcript
(A) Alternative splicing of Stat3 pre-mRNA and generation of Stat3 isoforms. The 3 region of Stat3 pre-mRNA (exon 21 through 3 UTR) is
diagrammed in the middle line; exons (closed boxes) and introns (lines) are indicated. Dashed lines indicate patterns of alternative splicing.
Arrowheads represent primers used for detection of Stat3 and Stat3 mRNAs by RT-PCR (right, RNA). The Stat3 and Stat3 proteins
(Schaefer et al., 1995) are diagrammed in the upper and lower boxes. The DNA binding domain (DBD), SH2 domain, and sites of tyrosine or
serine phosphorylation are indicated. Immunoblotting with a pan-specific Stat3 antibody detects Stat3 and Stat3 in a myeloid cell lysate
(right, Protein).
(B) Proposed alternative splicing in the Stat3 gene. The 3 portion of exon 22 and the 5 portion of exon 23 are diagrammed. The AG dinucleotide
and polypyrimidine tract embedded in exon 23 are shown in bold and underlined.
(C) Alignment of Stat3 nucleotide sequences from vertebrate species in the vicinity of the putative Stat3 splice acceptor site. An embedded
TAG trinucleotide in mouse and corresponding trinucleotides from other species are underlined.
(D) Summary of Stat3 splice acceptor site mutations. The pre-mRNA is shown schematically at top, with wild-type and mutant sequences
below. Targets of dinucleotide and polypyrimidine mutations are boxed, as is the region in which a MfeI site was introduced. Mutations are
designated at left. To distinguish exogenous Stat3 pre-mRNA substrates from the endogenous Stat3 message in transfection experiments,
a foreign sequence tag (HA) was inserted upstream of exon 21. Arrowheads represent primers used for RT-PCR.
(E) Stat3 mRNA isoforms in cells transfected with the Stat3 minigene. Cos-7 cells were transfected with wild-type or mutant Stat3 minigenes,
designated as in (D). Stat3 mRNA was detected RT-PCR using primers specific for exogeneous Stat3. The Stat3 and Stat3 isoforms are
indicated by arrowheads.
amounts of nuclear extract from OSM-treated MEFs Stat1 (Figure 3E, right). Taken together, these results
indicate that formation of specific, Stat3-dependentwere analyzed for DNA binding activity against the CRE
element, no significant difference between genotypes DNA-protein complexes is impaired in at least some
Stat3-deficient tissues and suggest that Stat3 canwas observed (Figure 3C). These observations were ex-
tended to primary hepatocytes from wild-type, heterozy- contribute substantially and disproportionately to over-
all Stat3 DNA binding activity.gous, or Stat3-deficient mice. Basal and IL-6- or OSM-
inducible SIE binding activities were consistently and
progressively reduced in heterozygous and homozy- Altered Transcriptional Activation by Stat3 in
Stat3-Deficient MEF Cellsgous Stat3-deficient hepatocytes in comparison to
wild-type cells (Figure 3D, compare lanes 5–10 to lanes The impairment of Stat3 DNA binding activity in Stat3-
deficient cells prompted us to compare Stat3-depen-2–4). SIE binding complexes from primary hepatocytes,
like those from MEFs, contained Stat3 but no detectable dent transcriptional activation in wild-type and Stat3-
Cell
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Figure 2. Knockin Mutagenesis of the Mouse Stat3 Splice Acceptor Site
(A) The 3 portion of the wild-type Stat3 locus is diagrammed at top. Exons are indicated by filled boxes. The targeting vector is diagrammed
in the second line from top. The TK-neo cassette is indicated by open boxes and the flanking loxP sites by filled triangles. Splicing mutations
and a novel MfeI restriction site are indicated by the asterisk. The homologous recombination product is diagrammed in the third line from
top (Stat3 flox). The mutant Stat3 locus as configured after cre-mediated excision of the TK-neo cassette is diagrammed at bottom.
(B) Analysis of ES cells. G418-resistant ES clones were screened by Southern hybridization following HindIII digestion of genomic DNA (left,
HindIII). The 8 and 10 kb fragments from wild-type (Stat3) and mutant (Stat3flox) alleles, respectively, are indicated. GANC-resistant ES clones
were screened by Southern hybridization following MfeI digestion of genomic DNA (right, MfeI). The wild-type and mutant MfeI fragments at
14 and 5 kb are indicated.
(C) Analysis of F1 mice. MfeI-digested genomic DNA was analyzed by Southern hybridization. Genotypes are designated at top; the 14 kb
wild-type and 5 kb mutant fragments are indicated.
(D) Lack of Stat3 mRNA in Stat3/ mice. Total RNA was prepared from livers of Stat3/, Stat3/, and Stat3/ mice; Stat3 mRNA
isoforms were detected by RT-PCR (top). The positions of Stat3 and Stat3 isoforms are indicated at right. A selective assay for Stat3
transcripts confirmed the absence of this isoform in Stat3/ animals (middle). Expression of -actin was assessed in the same samples
(bottom).
deficient MEFs, using a transient reporter assay under tional activity. We reasoned that a comparative analysis
of global gene expression in these cells would revealconditions of serum supplementation. Stat3-dependent
promoters from the genes for 2-macroglobulin (2MG- the scope of this effect, identifying potential targets for
direct or indirect regulation by Stat3. From wild-typeluc), c-fos (c-fos-luc), and p53 (p53-luc) were tested, as
well as an artificial promoter containing a single SIE site or Stat3-deficient MEF cells, maintained in 10% serum
as in the transient transfection assays described above,(pSIE-luc). The activity of each promoter examined was
substantially reduced in Stat3-deficient cells relative to probes were prepared and hybridized to oligonucleotide
wild-type (Figure 4A). The observed reduction in Stat3- arrays containing 9977 functional probe sets. To mini-
dependent promoter activity was the result of a specific mize differences resulting from intergroup variation,
effect, since expression of the cotransfected Renilla lu- cRNA probes were prepared from pooled clones (4) of
ciferase gene, under control of the HSV thymidine kinase Stat3/ or Stat3/ MEF cells, each obtained from a
promoter, was similar in wild-type and Stat3-deficient different embryo. The entire hybridization experiment
cells (data not shown). was replicated three times using cRNA probes from
independently prepared MEF pools.
About half (4945) of the probe sets were consistentlyEffects of Stat3 Deficiency on Expression
of Endogenous Transcripts expressed in both wild-type and Stat3-deficient MEF
cells. In addition, 28 transcripts were scored as presentThe results of transient reporter assays in transfected
MEFs suggested that Stat3modulates Stat3 transcrip- only in wild-type, while nine transcripts were present
Modulation of Systemic Inflammation by Stat3
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Figure 3. Absence of Stat3 Protein and Im-
paired Stat3 DNA Binding in Stat3/ Mice
(A) Absence of Stat3 protein expression and
activation in MEF cells from Stat3/ mice.
MEF cells derived from Stat3/, Stat3/,
or Stat3/ animals were left untreated
(none) or were treated with IL-6 (10 ng/ml),
OSM (10 ng/ml), LIF (10 ng/ml), IFN (10 ng/
ml), or EGF (100 ng/ml) for 15 min at 37C.
Total cell lysates (25 g) were analyzed by
Western blot using a phosphotyrosine-spe-
cific anti-Stat3 antibody (Ab:Stat3-pTyr). The
same membranes were stripped and re-
probed with a pan-specific anti-Stat3 anti-
body (Ab:Stat3).
(B) Reduced SIE binding activity in Stat3-
deficient MEFs. MEFs from Stat3/ (lanes
2–7), Stat3/ (lanes 8–13), and Stat3/
(lanes 14–19) mice were treated with IL-6,
OSM, LIF, IFN, or EGF as in (A), and nuclear
extracts (2g) were assayed for binding to an
SIE-containing probe. No lysate was added to
the sample in lane 1.
(C) cAMP-responsive element (CRE) binding
activity is intact in Stat3-deficient MEFs. Nu-
clear extracts (2g) from the OSM-stimulated
MEFs in (B) were assayed as above for bind-
ing to an CRE-containing probe.
(D) Impaired SIE binding activity in Stat3-
deficient hepatocytes. Primary hepatocytes
from Stat3/ (lanes 2–4), Stat3/ (lanes
5–7), and Stat3/ (lanes 8–10) mice were left
untreated () or were treated with IL-6 (10
ng/ml) or OSM (10 ng/ml) for 15 min at 37C.
Nuclear extracts (2 g) were assayed for
binding to an SIE-containing probe. No lysate
was added to the sample in lane 1.
(E) Detection of Stat3, but not Stat1, in SIE
bound complexes from OSM-stimulated
cells. SIE binding reactions containing ex-
tracts from OSM-treated MEFs (lanes 1–4) or
primary hepatocytes (lanes 5–8) were incu-
bated prior to gel electrophoresis with anti-
body against Stat3 (lanes 3 and 7) or Stat1
(lanes 4 and 8), or with purified rabbit IgG
(lanes 2 and 6). No antibody was added to
the samples in lanes 1 and 5.
only in Stat3-deficient MEFs. A total of 283 genes ex- type or heterozygous littermates and were fertile. Devel-
opment of lymphoid and myeloid lineages was grosslyhibiting differential expression (p 	 0.05) were grouped
by hierarchial clustering (see Supplementary Data at intact as assessed by cytometric analysis of splenic,
thymic, and bone marrow subsets (data not shown).http://www.cell.com/cgi/content/full/108/3/331/DC1).
Of these, 36 known genes showed greater than 2-fold Among the Stat3-deficient group we did observe, how-
ever, two incidental deaths in which postmortem exami-differential expression and are listed in Table 1, together
with 23 additional known genes that were consistently nation revealed signs of pulmonary thromboembolism,
hepatic necrosis, vascular congestion, and dissemi-scored as present in one genotype and absent in the
other. The determination of differential gene expression nated intravascular coagulation (data not shown), histo-
pathologic findings that are reminiscent of septic shockby oligonucleotide array analysis was confirmed for a
subset of known genes by RT-PCR. In agreement with (Karima et al., 1999). This suggested the presence of
one or more uncontrolled environmental variables withthe microarray data, steady-state levels of Crip, Tfpi,
Ptn, and Scya2 RNA were elevated in Stat3-deficient differential effects on wild-type and Stat3-deficient
mice.MEFs, while Sdf1 and Igfbp5 transcripts were elevated
in wild-type MEFs (Figure 4B). With the knowledge that Stat3 regulates the APR, we
examined the responses of wild-type and Stat3-defi-
cient mice to bacterial endotoxin, a trigger of systemicImpaired Recovery from Endotoxic Shock
in Stat3-Deficient Mice inflammation. Age- and sex-matched cohorts of mice
were challenged intraperitoneally with two differentHomozygous Stat3-deficient mice exhibited no appar-
ent developmental abnormalities in comparison to wild- amounts of bacterial lipopolysaccharide (LPS) and ob-
Cell
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Figure 4. Impaired Stat3-Dependent Transcription in Stat3-Deficient MEFs
(A) MEFs were transiently transfected with the firefly luciferase reporter constructs 2MG-luc, c-fos-luc, p53-luc, or SIE-luc and the Renilla
luciferase pRL-TK construct and maintained in 10% serum. At 48 hr after transfection, total cell lysates were tested for luciferase activity.
The ratio of firefly to Renilla luciferase activity is reported (relative luciferase activity). Means and standard errors of three replicate assays
are given.
(B) Confirmation of differential gene expression in wild-type and Stat3-deficient MEF cells by RT-PCR. Total RNA from Stat3/ (lanes 1–4)
or Stat3/ (lanes 5–7) MEFs, maintained in 10% serum, was reverse transcribed; cDNA was left undiluted (lanes 2 and 5), diluted 1:4 (lanes
3 and 6), or diluted 1:16 (lanes 4 and 7) and used as a template for amplification of Ptn, Crip, Tfpi, Scya2, Sdf1, Igfbp5, and -actin transcripts.
Reverse transcriptase was omitted from the sample in lane 1. Products were detected with ethidium bromide.
served over two weeks (Figures 5A and 5B). The wild- initial period, as ATN was undetectable in wild-type or
Stat3-deficient mice that died by 30 hr after LPS chal-type and Stat3-deficient groups showed similar mortal-
ity over the first 48 hr, with all mice exhibiting profound lenge (Figures 5E and 5F).
lethargy over the first two days. After the initial two-day
period, however, a substantial fraction of the wild-type Regulation of LPS-Responsive Genes by Stat3
The principal cause of ATN is ischemia of peripheralgroup recovered. Of the wild-type animals that remained
alive at 48 hr after LPS, six of six that had received 250 organs, accompanied by hypotension and shock (Co-
tran et al., 1999). The presence of ATN in the LPS-chal-g and four of seven that had received 500 g were still
alive at 14 days. In contrast, the Stat3-deficient mice lenged, Stat3-deficient mice suggested that these ani-
mals may have suffered a more severe or protractedwere less likely to recover: of the mutant animals still
alive at 48 hr after LPS, three of seven in the 250 g period of shock than their wild-type littermates. Acti-
vated macrophages from Stat3-deficient mice andgroup and none of six in the 500 g group were alive
at 14 days. wild-type littermates produced similar levels of TNF,
IL-1, IL-6, and IL-10 in response to LPS (data notStat3-deficient mice that had died at about 96 hr
after administration of LPS consistently exhibited severe shown), suggesting that the detection of LPS and the
subsequent production of proinflammatory cytokines byacute tubular necrosis (ATN) in the kidney as well as
general signs of septic shock, including thymic and he- macrophages is intact in the absence of Stat3. The
normal responsiveness of Stat3-deficient macro-patic necrosis. The ATN was characterized by multifo-
cal, coalescing areas in the proximal tubules, where phages to LPS distinguishes these cells from their Stat3-
deficient counterparts, which exhibit marked increasesnecrotic tubular epithelial cells had sloughed into the
tubular lumen. Basement membranes of the affected in LPS induction of TNF and IL-6 (Takeda et al., 1999).
We therefore considered that some detrimental effectstubules were exposed or partially covered by attenuated
tubular epithelial cells. There were occasional mitotic of bacterial endotoxin might be sustained by the hepatic
APR itself and that Stat3 might play a role in opposingfigures within the remaining epithelial lumen, suggesting
attempted regeneration (Figure 5D). By comparison, these effects.
The effect of Stat3-deficiency on systemic inflamma-wild-type mice that had recovered and were sacrificed
at 96 hr after LPS exhibited no evidence of ATN (Figure tion was therefore examined as part of a genome-wide
analysis of the hepatic APR, details of which will be5C). The presence of ATN distinguished Stat3-deficient
mice that died during the later phase of the LPS re- presented elsewhere (J.-Y.Y. and S.D., unpublished
data). Stat3/ mice and wild-type littermates were in-sponse from mutant and wild-type mice that died in the
Modulation of Systemic Inflammation by Stat3
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Table 1. Differential Gene Expression in Wild-Type and Stat3-Deficient MEF Cells
Signal Intensityd
GenBanka Name Description Changeb Foldc Wild-Type Mutant
Inflammatory Mediators and Markers
M13018 Crip cysteine-rich intestinal protein  6.0e 310 
 154 1,859 
 285
Y10007 Fap fibroblast activation protein  3.8e 234 
 57 882 
 75
X66473 Mmp1 matrix metalloproteinase 1  3 238 
 59 731 
 92
L03529 Cf2r thrombin receptor  2.6 1,849 
 760 4,744 
 118
AF004833 Tfpi tissue factor pathway inhibitor  2.6 402 
 114 1,050 
 242
AF006741 Coch coagulation factor C homolog  8 1,633 
 280 225 
 67
D00466 Apoe apolipoprotein E  4,636 
 2,404 N.D.
AI786089 Kng similiar to human kininogen precursor  1,325 
 262 N.D.
M81591 Mme membrane metalloendopeptidase  961 
 222 N.D.
Growth Factors, Cytokines
D90225 Ptn pleiotrophin  3.5 556 
 243 2,039 
 634
AF100777 Wisp1 connective tissue growth factor-related  2.3e 4,448 
 828 10,953 
 808
AF019048 Tnfsf11 receptor activator of NFB ligand  2.2 229 
 58 500 
 37
U88567 Sdf5 secreted frizzled related protein sFRP-2  5.2 14,204 
 4,206 3,343 
 2,655
U43836 Vrf VEGF-related factor  2.1 2,902 
 97 1,517 
 360
L32838 Il1rn interleukin 1 receptor antagonist  2 3,895 
 659 2,115 
 553
L12447 Igfbp5 insulin-like growth factor binding protein 5  2.2 17,538 
 1,986 8,146 
 1400
L12030 Sdf1 stromal cell derived factor 1  3.2 8,314 
 1,363 2,700 
 178
D86370 Msln megakaryocyte potentiating factor  1,120 
 406 N.D.
Signal Transduction
AB011030 Prdc-pending protein related to DAN and cerberus  4.5 717 
 175 3,434 
 89
AB020886 Akap12 src suppressed C kinase substrate  3.3 1,474 
 417 4,998 
 574
U22399 KCdkn1c cdk-inhibitor p57KIP2  2.2 973 
 147 2,238 
 342
AF033350 Cdcrel septin protein family member  N.D. 2,248 
 182
X65128 Gas1 growth arrest specific 1  2.7 10,044 
 521 4,077 
 826
m57683 Pdgfra PDGF  receptor  2.4 1,693 
 336 789 
 258
M21828 Gas2 growth-arrest-specific gas2 protein  2.6 10,058 
 2,087 4,274 
 1,414
L31397 Dnm dynamin  2.2 5,929 
 498 2,875 
 39
M21065 Irf1 mouse interferon regulatory factor 1  2,105 
 39 N.D.
AJ250669 Gab1 Grb2-associated binding protein 1  495 
 76 N.D.
Transcription Factors
U61362 Tle1 groucho-related gene 1 protein  2.9 4,232 
 272 1,560 
 30
M31418 Ifi202a interferon activated gene 202  2.3 506 
 4 272 
 103
X77602 Usf2 Upstream transcription factor 2  2,046 
 455 N.D.
X71422 Hoxd11 homeobox protein D11  1,387 
 280 N.D.
U40576 Sim2 drosophila single-minded homolog  1,190 
 214 N.D.
U61110 Eya1 similar to drosophila eyes absent 1  378 
 19 N.D.
U10374 Ppar peroxisome proliferator-activated receptor   341 
 84 N.D.
Intermediary Metabolism
AF059213 Ch25h-pending cholesterol 25-hydroxylase  2.7 694 
 100 1,963 
 96
X13586 Bpgm 2,3-bisphosphoglycerate mutase  2.1 593 
 158 1,164 
 111
U12961 Dia4 NAD(P)H:menadione oxidoreductase  2 334 
 26 747 
 175
AB011451 Chst2 N-acetylglucosamine-6-O-sulfotransferase  N.D. 771 
 116
U96401 Aldh1a4 aldehyde dehydrogenase Ahd-2-like  2.8e 5,327 
 678 2,026 
 331
AB018421 Cyp4a10 cytochrome P-450  138 
 49 N.D.
Cellular Adhesion
X66084 CD44 CD44 antigen, hyaluronic acid receptor  2.3 816 
 160 2,013 
 299
U37501 Lama5 laminin  2.8 3,831 
 519 1,541 
 568
X83506 Utm G-utrophin  813 
 265 N.D.
U12889 Klra8 Ly-49 family member  225 
 64 N.D.
Miscellaneous
X56690 Cbx1 chromobox homolog  2.8 252 
 26 755 
 189
U74683 Ctsc cathepsin C; DPPI  2.7 852 
 31 2,585 
 91
X60367 Rbpl cellular retinol binding protein I  2.4e 503 
 75 1,270 
 188
U72680 Fxyd5 ion channel homolog RIC  2.4 1,438 
 460 3,572 
 326
U19271 Ly75 receptor DEC205  2.2 437 
 110 945 
 39
U55060 Lgals9 beta-galactoside binding lectin  N.D. 1,483 
 381
AF045692 Slc16a2 X-linked PEST-containing transporter  2.9 478 







GenBanka Name Description Changeb Foldc Wild-Type Mutant
Miscellaneous
AF107994 Mest peg1/MEST protein  2.7 3,721 
 199 1.659 
 881
U23095 immunoglobulin heavy chain V region  1,336 
 105 N.D.
AJ237847 Rbmx heterogeneous nuclear ribonucleoprotein G  1,137 
 429 N.D.
U89652 Brca2  917 
 155 N.D.
J04620 Prim1 primase p49 subunit (priA)  669 
 121 N.D.
AF080090 Sema3f semaphorin IV isoform b  649 
 149 N.D.
AF017258 Ear3 eosinophil associated RNAse 3 precursor  584 
 100 N.D.
a All annotated genes (36 of 9,977 probe sets) with greater than 2-fold differential expression (p 	 0.05) and all annotated genes (23 of 9,977
probe sets) consistently expressed in cells of one genotype and absent in the other.
b Plus sign indicates increased relative expression in mutant cells; minus sign indicates decreased relative expression in mutant cells.
c Ratio of larger to smaller normalized signal intensity.
d Mean average difference (perfect match  mismatch) 
 SEM (n  3); N.D., not detected.
e p 	 0.01.
jected intraperitoneally with a sublethal dose of LPS, (Irfg15), and X-box binding protein 1 (Xbp1) have been
shown previously to respond to inflammation. Otherand RNA was harvested at various times up to 48 hr.
These RNA samples were used to interrogate oligonu- prominent functional groups include genes involved in
intracellular sorting, cytoarchitecture, translational initi-cleotide arrays containing 12,488 probe sets. The time
course experiment was replicated three times using ation, and protein degradation.
In this set, 60 of the 64 genes were overexpressed inprobes from independently injected mice.
Of 8717 markers scored as present in either wild- the Stat3-deficient animals, and many of these RNAs
exhibited increased accumulation throughout the periodtype or mutant samples at one or more time points, 776
markers exhibited significant (p 	 0.01) changes over of observation, even at zero time and at 48 hr, when
expression of most markers had returned to baseline intime in wild-type or mutant animals. Within this group,
which we term the LPS-responsive set, 63 genes exhib- the wild-type animals. The results obtained by microar-
ray assay were confirmed by RT-PCR for three RNAsited significant temporal changes in both genotypes.
Most of these markers, which include genes for estab- that were overexpressed (Ifrg15, Gja1, and Spf45) and
one RNA that was underrepresented (Pk-3) in livers oflished acute phase proteins such as serum amyloid A,
orosomucoid, heparin cofactor II, manganese superox- Stat3-deficient mice (Figure 6B). The bias toward over-
expression of LPS-responsive genes in the mutant miceide dismutase, and the serine protease inhibitor Spi2,
had similar expression patterns in wild-type and Stat3- supported the proposition that Stat3 serves negative
regulatory functions in the APR.deficient animals (see Supplementary Data at http://
www.cell.com/cgi/content/full/108/3/331/DC1). If Stat3 were to act in this way, then its contribution
to total Stat3 activity, relative to that of Stat3, wouldTo assess the specific contribution of Stat3 to the
hepatic acute phase response, we interrogated the LPS- be expected to change in the course of the response.
To test this possibility, we monitored accumulation ofresponsive set of 776 markers for genes whose expres-
sion in wild-type and Stat3-deficient mice differed Stat3 transcripts in wild-type mice after LPS adminis-
tration. While the total amount of Stat3 RNA was nearlysignificantly (p 	 0.01). The number of genotypically
differential genes obtained, 128, was substantially constant over the course of the experiment, the steady-
state level of Stat3 RNA increased sharply by 3 hr aftergreater than that expected at random (0.01 776	 10).
Of particular importance is the fact that the directionality LPS administration, diminishing somewhat by 24 hr but
remaining elevated above baseline even at 48 hr (Figureof the genotypic difference was left unspecified by the
interrogation, allowing us to assess trends in the data 6C). A parallel assay of Stat3 protein yielded similar
results (data not shown). Taken together, our observa-without prejudice. In fact, a striking bias in the expres-
sion of these genes was observed, with the overwhelm- tions indicate that Stat3 negatively regulates a subset
of LPS-responsive genes in liver and suggest that thising majority (124/128) exhibiting increased accumula-
tion in the Stat3-deficient animals, relative to wild-type. function is important for recovery from endotoxic chal-
lenge.In most instances these transcripts were overexpressed
at baseline and overinduced by LPS.
The group of genotypically differential markers in- Discussion
cludes 65 known genes (Figure 6A and see Supplemen-
tary Data at http://www.cell.com/cgi/content/full/108/3/ Stat3, despite its usual presence as a minor isoform,
can modify Stat3 activity in substantial and physiologi-331/DC1). At least 11 of these, including the genes for
apolipoprotein E (Apoe), ceruloplasmin (Cp), comple- cally significant ways. The DNA binding activity of Stat3
and its ability to stimulate transcription from a varietyment component C1r (C1r), connexin 43 (Gja1), cyto-
chrome P450 A10 (CYP4A10), elongation factor eIF2 of promoters are impaired in embryonic fibroblasts from
Stat3-deficient mice, implying that Stat3 can modu-(eIF2), endothelial monocyte-activating polypeptide II
(EmapII), fibronectin receptor  (Fnrb), hypoxia-induc- late the overall activity of Stat3. Stat3 homodimers are
more stable than those of Stat3 and, as a result, exhibitible factor 1 (Hif1a), interferon  responsive gene 15
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Figure 5. Decreased Recovery from LPS Challenge in Stat3-Deficient Mice
(A and B) Stat3/ mice exhibit impaired recovery from endotoxic shock. Survival of Stat3/ or Stat3/ mice is plotted as a function of
time after administration of 250 g (A) or 500 g (B) LPS. Cohorts were matched for age and sex. Mice were monitored for 2 weeks, with no
additional mortality observed after 7 days.
(C–F) Acute tubular necrosis in kidneys of Stat3/ mice following challenge with LPS. Representative histological sections of kidneys from
(C) surviving Stat3/ mice that were sacrificed at 96 hr after LPS administration; (D) Stat3/ mice dead by 96 hr after LPS administration;
(E) Stat3/ mice dead by 30 hr after LPS administration; and (F) Stat3/ mice dead by 30 hr after LPS administration. Hematoxylin and
eosin stain. Examination of at least three different mice from each group showed similar findings.
greater DNA binding activity in vitro (Park et al., 2000). Stat3 can do so (Caldenhoven et al., 1996). Second,
in melanoma cells, Stat3 suppresses transcription ofMoreover, the stability in vitro of DNA bound Stat3/
heterodimers is also likely to be greater than that the Fas gene; Stat3 opposes this effect (Ivanov et al.,
2001). Third, in embryonic fibroblasts or ES cells hetero-of Stat3 homodimers, as formation of DNA bound
Stat3/ heterodimers is greatly favored over formation zygous for ablation of Stat3, the amount of total Stat3
protein is reduced and Fas transcription is increased;of DNA bound Stat3 homodimers even when Stat3 is
in large excess of Stat3 (Caldenhoven et al., 1996). forced expression of Stat3 in these cells induces a
further increase in Fas expression, consistent with op-Thus, the superior stability of Stat3/ heterodimers can
provide Stat3 with considerable leverage. posing roles for Stat3 and Stat3 in the regulation of
this locus (Ivanov et al., 2001). The prediction that Stat3The absence of a transactivation domain suggested
that dimers containing Stat3 differ functionally from serves distinctive physiologic functions was satisfied by
phenotypic analysis of Stat3-deficient mice.species composed solely of the  isoform, and several
previous reports are consistent with this. First, Stat3 The murine response to LPS can be divided tempo-
rally into two stages: one leading to the production ofis unable to stimulate transcription of IL-6-responsive
genes in transfected cells under conditions in which proinflammatory cytokines and the other involving the
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Figure 6. Regulation of the Hepatic Response to LPS by Stat3
(A) Increased accumulation of LPS-responsive transcripts in Stat3-deficient mice. RNA expression in livers of Stat3/ and Stat3/ mice
was assessed at 0, 3, 6, 12, 24, and 48 hr after administration of LPS. Analyses were performed in triplicate from independently treated
animals except for the Stat3/ zero time point, which was assayed in duplicate. The 65 known, LPS-responsive genes exhibiting differential
expression between genotypes (p 	 0.01) were clustered hierarchically. Time after LPS administration is indicated, in hours, at top. Red
represents expression above and green represents expression below the median value; black represents expression at the median. Markers
whose expression was scored as absent are coded as gray. Genes are listed at right.
(B) Confirmation of differential gene expression in wild-type and Stat3-deficient livers by RT-PCR. Total liver RNA from LPS-treated, Stat3/
(right), or Stat3/ (left) animals, corresponding to each time point in the microarray experiment of (A), was reverse transcribed and used as
a template for amplification of Ifrg15, Gja1, Spf45, and Pk-3 transcripts. Products were detected with ethidium bromide.
(C) Induction of Stat3 transcripts in liver after intraperitoneal administration of LPS. Total liver RNA from LPS-treated wild-type mice was
reverse transcribed and used as a template for selective amplification of Stat3 (top) or total Stat3 (bottom) transcripts. Products were
fractionated by agarose gel electrophoresis and detected with ethidium bromide.
actions of those cytokines on target organs such as capable of exerting positive or negative effects on gene
expression, depending on cellular and genetic context,the liver. While the decreased ability of Stat3-deficient
mice to recover from LPS challenge could, a priori, have its role as a negative regulator appears to dominate in
the endotoxin-induced APR. Increases in both restingreflected abnormalities at either or both of these stages,
the ability of Stat3-deficient mice to mount a normal and LPS-induced expression levels were observed, sug-
gesting that Stat3-deficiency mimics the chronic sys-cytokine response to LPS indicated a defect at the latter
stage. temic inflammatory state typically seen in patients with
rheumatoid arthritis and other autoimmune syndromes.Two additional lines of evidence are consistent with
this interpretation. First, selective ablation of Stat3was The Stat3-deficient mice may therefore provide a
model for these chronic inflammatory states.accompanied by a striking and largely unidirectional
alteration in the expression of LPS-responsive genes in Examination of the LPS-inducible genes most signifi-
cantly affected by ablation of Stat3may provide insightliver. Second, the administration of LPS is followed by
an increase in the hepatic expression of Stat3 RNA into the pathology observed in Stat3-deficient mice.
Many of the markers that are overexpressed in theseand protein, relative to that of Stat3. While Stat3 is
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animals play intimate roles in the maintenance of vascu- crepancy may be explained in part by alternative RNA
lar function and in the responses of vascular tissues to splicing (Lopez, 1998), which may occur at 35%–40%
inflammation. Cytochrome P450a isoforms (represented of human loci (Brett et al., 2000; Lander et al., 2001;
by CYP4A10) and connexin 43 (Gja1) are known to be Modrek et al., 2001). A fundamental question concerns
induced by LPS in liver and kidney (Warren et al., 2001; the extent to which alternative isoforms of a particular
Fernandez-Cobo et al., 1998). Metabolites generated by transcriptional regulator contribute to global patterns of
cyctochrome P450 synergize strongly with endothelin gene expression. Stat1, Stat3, Stat5, and Stat6 each
to induce renal vasoconstriction (Okeyan et al., 1997), encode alternatively spliced RNA isoforms (Caldenho-
while connexin 43 has been implicated in renal inflam- ven et al., 1996; Patel et al., 1998; Sasse et al., 1997;
mation and in the genesis of renal tubular damage (Hillis Schaefer et al., 1995; Wang et al., 1996). Our observa-
et al., 1997). Fibronectin receptor  (Fnrb), or CD29, tions indicate that alternative splicing in transcriptional
supports neutrophil migration to endothelium in re- regulatory genes can be a potent source of proteomic
sponse to LPS (Ridger et al., 2001), while endothelial complexity. The presence of overexpressed and under-
monocyte-activating polypeptide II (EmapII) promotes expressed transcripts in Stat3-deficient MEF cells is
clot formation at endothelial surfaces (Kao et al., 1992) consistent with the ability of Stat3 to act intrinsically
and induces directional migration of inflammatory cells as a suppressor of transcription or in collaboration with
(Kao et al., 1994). All of these proteins are expected to coactivators as a stimulator of transcription. Which of
promote the pathogenesis of shock and may promote these effects dominates at a particular promoter would
the development of renal pathology in Stat3-deficient in principle depend on the presence of cis-acting regula-
mice. tory elements, the availability of transcriptional coactiva-
Other dysregulated genes may also contribute to the tors, and the relative amounts of active Stat3 and
failure of Stat3-deficient mice to recover from LPS Stat3. In addition, some genes that are differentially
treatment. These include not only additional inflamma- expressed in Stat3-deficient and wild-type MEFs may
tory markers, but also members of other functional have responded indirectly to removal of Stat3, for ex-
groups whose connection to pathogenesis are less obvi- ample, through the selective outgrowth of a subset of
ous. Further analysis of these genes in the context of MEFs during cell culture.
the LPS response may provide new targets for treatment Comparison of regulatory sequences in genes that
of endotoxic shock. are coordinately regulated by Stat3may provide insight
Several lines of evidence indicate that the Stat3- into the regulation of Stat3 activity by this isoform. Of
deficient phenotype does not merely result from a low- the genes that were differentially expressed in Stat3-
ered abundance of Stat3 dimers, but rather reflects deficient and wild-type MEF cells (Table 1), the promoter
properties peculiar to the Stat3 isoform. First, in mice regions of 12 have been described, either in the mouse
bearing a mutated Stat3 promoter element, Stat3 protein genes themselves or in human orthologs. All of these
is substantially reduced in several tissues, including kid- promoter regions contain canonical Stat3 binding sites,
ney, thymus, and spleen; these animals, unlike Stat3- including ten whose regulation had previously not been
deficient mice, exhibit no increase in susceptibility to linked to Stat3. The survey of differential gene expres-
LPS (Narimatsu et al., 2001). Second, ablation of the sion in Stat3-deficient and wild-type MEF cells repre-
Stat3 gene in hepatocytes impairs LPS induction of sev- sents a first step in understanding how the Stat3 iso-
eral acute phase proteins, including serum amyoid P form contributes to proteomic complexity, but the
and SAA isoforms 1 and 2 (Alonzi et al., 2001), while physiologic nuances of regulation by Stat3, as it occurs
in Stat3-deficient animals these proteins are induced. in multiple cell types under various conditions, are likely
Third, conditional ablation of total Stat3 in macrophages to be richer.
(Takeda et al., 1999), thymic epithelial cells (Sano et al.,
2001), or keratinocytes (Sano et al., 1999) is accompa-
Experimental Procedures
nied by abnormalities in cytokine production, thymocyte
development, and skin abnormalities, respectively, that DNA Constructions
are not observed in Stat3-deficient animals. Notably, The Stat3 gene (Shi et al., 1996) was isolated from a 129/Ola mouse
genomic library and partially digested with Sau3AI. A 5.5 kb DNAmacrophages, thymic epithelial cells, and keratinocytes
fragment spanning Stat3 from exon 21 through the 3 UTR wasthat are heterozygous for Stat3 lack intermediate pheno-
subcloned into the BamHI site of pBluescript to generate pSK/Stat3.types and are indistinguishable from their wild-type
Point mutations were introduced by site-directed mutagenesis andcounterparts (Takeda et al., 1999; Sano et al., 1999,
confirmed by DNA sequencing. To build the Stat3 splicing con-
2001). Thus, the published evidence does not support struct, genomic fragments were excised from the resulting mutant
an effect of low abundance. We conclude that the physi- plasmids (pSK/Stat3-E23M, -YI, -YII, -YIII, -TG, -YITG, -YIITG,
ologic consequences of Stat3 deficiency are distinct -YIIITG) with EcoRI and NotI, subcloned into the pcDNA3.1 mamma-
lian expression vector, and tagged by ligation of hemagglutinin-from those observed when the amount of total Stat3
encoding (HA) oligomers between the BamHI and EcoRI sites.protein is reduced or when Stat3 is selectively ablated
To obtain pSK/Stat3-YIIITG-neoTK, the Stat3 targeting con-in a variety of cell types.
struct, a KpnI-BstXI DNA fragment containing neomycin resistanceOur observations provide an opportunity to assess
(neo) and thymidine kinase (TK) genes, flanked by loxP sites, was
how alternative splicing within a regulatory gene affects excised from the plasmid pNTL (gift of Allan Bradley, Baylor College
global gene expression. The human genome contains of Medicine) and ligated into the HindIII site of pSK/Stat3-YIIITG.
about as many protein-encoding genes as do the ge-
nomes of some invertebrate species, although the com- Generation of Stat3-Deficient Mice
plexity of the human proteome may be substantially The targeting construct pSK/Stat3-YIIITG-neoTK (20 g) was linear-
ized with KpnI and introduced into 129/SvJ-derived ES cells (Ge-larger (Lander et al., 2001; Venter et al., 2001). This dis-
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nome Systems) by electroporation (0.23 kV, 500 F, BioRad). Trans- measure transfection efficiency. Luciferase activity was assayed 48
hr after transfection.fected cells were cultured in the presence of G418 (300 g/ml)
for 10 days. G418-resistant clones were screened for homologous
recombination by Southern hybridization, and mutation was con- Histological Analysis
firmed by DNA sequencing. Mice were fixed in 10% buffered formalin for several days before
ES cell clones bearing correctly mutated Stat3 were transfected embedding in paraffin. Sections (5m) were stained with hematoxy-
with 50 g of the cre expression plasmid pOG231 (gift of Steve lin and eosin.
O’Gorman, Salk Institute) and cultured in the presence of 2 M
gancyclovir; resistant clones were screened for excision of loxP- LPS Administration
neo-TK-loxP by Southern hybridization. ES cell clones scoring posi- Mice (13–15 weeks old) were injected intraperitoneally with 250 or
tive for excision were injected into C57BL/6 blastocysts. Chimeric 500 g lipopolysaccharide (E. coli strain 0111:B4, DIFCO Labora-
mice were backcrossed to the C57BL/6 strain, and germline trans- tories) in 100 l saline solution as described (Pfeffer et al., 1993).
mission of the mutant allele was confirmed by Southern hybrid-
ization. Oligonucleotide Array Hybridization and Statistical Analysis
For analysis of gene expression in MEF cells, four clones of Stat3
wild-type and Stat3-deficient MEF cells, each obtained from aRNA Isolation and Analysis
different embryo, were grown independently to 80%–90% conflu-Total RNA was isolated from tissues disrupted by the phenol-guani-
ency. Similar numbers of cells from each Stat3/ or Stat3/dine isothiocyanate method (Life Technologies). To assay spliced
clone (about 106 per clone) were combined, and total RNA wasStat3 transcripts, total RNA was reverse transcribed (AMV reverse
prepared by silica gel adsorption (Qiagen). For analysis of hepatictranscriptase; Boehringer Mannheim) and amplified by the PCR us-
gene expression, total RNA was prepared from livers of LPS-treateding primers specific for exogenous Stat3 (5-CGCGGATCCGCGAT
animals using the TRIzol reagent (Molecular Research Center). Fol-GGGGTACCCTTATGATGTGCCAGATTATGCCGAATTCCGG -3 and
lowing isolation of polyadenylated RNA, double-stranded cDNA was5-CAAACTGCCCTCCTGCTG-3) or endogenous Stat3 (5-GTGC
synthesized by reverse transcriptase (Life Technologies) using a T7-TGCCCCGTACCTGAAGA-3 and 5-CGGGATCCGGAGGGCAGGC
(dT)24 primer (5-GGCCAGTGAATTGTAATACGACTCACTATAGGGGGGCAGGACA-3). Stat3 transcripts were assayed using a general
AGGCGG-[dT]24-3). Biotin-labeled, antisense cRNA was transcribedStat3 primer (5-GCAGGTGTCTCAAGTCAC-3) and a Stat3-spe-
from cDNA templates using T7 RNA polymerase (Enzo Biochem)cific primer (5-CATCTGTGTGACACCATT-3). Sequences of PCR
and hybridized to oligonucleotide microarrays (mouse U74A or U74Aprimers for Tfpi, Crip, Ptn (pleiotrophin), Scya2 (small inducible cyto-
v2; Affymetrix), each containing 9,977 (MEF) or 12,488 (liver) func-kine A2), Igfbp5, Sdf1, Ifrg15, Gja1, Spf45, and Pk-3 are available
tional oligonucleotide probe sets. Analyses were performed in tripli-upon request.
cate from independently prepared MEFs or from livers of individual,
LPS-treated mice. Hybridization intensities (average differences)Culture of Primary Cells
and assessments of presence or absence of a given transcript (ab-Mouse embryonic fibroblast (MEF) cells were prepared from individ-
solute call) were determined using Affymetrix Microarray Suite. Aver-ual 12- to 14-day-old mouse embryos as described (Hogan et al.,
age differences associated with transcripts judged to be present in1994) and maintained in DMEM containing 10% FBS, penicillin/
the RNA pools were further analyzed using GeneSpring 4.0 (Siliconstreptomycin (50 g/ml), and 2 mM L-glutamine. Primary hepato-
Genetics). The signal intensity of each probe was normalized to thecytes were prepared from livers as described (Hsiao et al., 2000)
median value of all intensities measured in the corresponding array.and cultured in William’s E medium containing 10% heat-inactivated
These array-normalized intensities were further normalized to thefetal bovine serum, 10 mM glucose, 10 mM HEPES (pH 7.55), 0.04%
median of all array-normalized intensities determined for that genesodium bicarbonate, penicillin/streptomycin (50 g/ml), insulin (0.5
over all hybridizations. Statistical comparisons of normalized wild-g/ml), and 1 nM dexamethasone.
type and mutant intensities were performed using Welch’s approxi-
mate t test with a significance cut-off of p 	 0.05 (MEF) or p 	Immunological Detection of Stat3 Protein
0.01 (liver). Hierarchial clustering was performed using the PearsonMEF cells were incubated overnight in DMEM containing 0.5% FBS
correlation coefficient as a distance metric.before stimulation for 15 min with LIF (10 ng/ml), OSM (10 ng/ml),
IL-6 (10 ng/ml), IFN (10 ng/ml), or EGF (100 ng/ml). Cells were lysed
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